ECHOPOINT MEDICAL LTD

Active United Kingdom

Manufacture of medical and dental instruments and supplies

6 employees website.com
Life sciences and medical technology Manufacture of medical and dental instruments and supplies
E

ECHOPOINT MEDICAL LTD

Manufacture of medical and dental instruments and supplies

Founded 9 Nov 2018 Active United Kingdom 6 employees website.com
Life sciences and medical technology Manufacture of medical and dental instruments and supplies
Accounts Due 30 Sept 2026 3 months remaining
Confirmation Submitted 6 May 2026 Next due 20 May 2027 11 months remaining
Net assets £3M £4M 2024 year on year
Total assets £4M £3M 2024 year on year
Total Liabilities £158K £517K 2024 year on year
Charges 2
2 outstanding

Contact & Details

Contact

Email

info@example.com

Website

www.example.com

Full company profile for ECHOPOINT MEDICAL LTD (11669397), an active life sciences and medical technology company based in United Kingdom. Incorporated 9 Nov 2018. Manufacture of medical and dental instruments and supplies. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type total-exemption-full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2019–2024)

Cash in Bank

£3.31M

Increased by £3.28M (+10659%)

Net Assets

£3.37M

Increased by £3.99M (+643%)

Total Liabilities

£158.45k

Decreased by £516.82k (-77%)

Turnover

N/A

Employees

6

Increased by 1 (+20%)

Debt Ratio

4%

Decreased by 1229 (-100%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 2
Grants 3

Investors (5)

Investor NameInvestor SinceParticipating Rounds
Investor 1Sept 2019Series A, Seed
Investor 2Sept 2019Series A, Seed
Investor 5Sept 2019Seed

Share Capital

Share Capital

Share allotments and capital structure

13 Allotments 465,968 Shares £8.22m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
5 Feb 202663,636£1.40m£22
26 Nov 20254,168£25k£6
25 Nov 20255,051£111k£22
25 Nov 20251,684£0£0
25 Nov 20251,684£0£0

Officers

Officers

3 active
Status
Adrien Emmanuel DesjardinsDirectorCanadianEngland489 Nov 2018Active
Nancy BriefsDirectorAmericanUnited States711 Oct 2024Active
Ucltf Corporate Directors LtdCorporate-directorUnited KingdomUnknown19 Feb 2024Active

Shareholders

Shareholders (12)

Utf General Partner Llp In Its Capacity As General Partner Of Ucl Technology Fund Lp
22.9%
112,013
Mnl (parkwalk) Nominees Limited
21.2%
103,864

Persons with Significant Control

Persons with Significant Control (2)

2 Active 2 Ceased
Active
Notified 26 Sept 2019
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
Active
Notified 19 Feb 2024
Nature of Control
  • Ownership Of Shares 25 To 50 Percent

Adrien Emmanuel Desjardins

Ceased 26 Sept 2019

Ceased

Malcolm Charles Finlay

Ceased 26 Sept 2019

Ceased

Group Structure

Group Structure

ECHOPOINT MEDICAL LTD Current Company

Charges

Charges

2 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
6 May 2026Confirmation StatementConfirmation statement made on 6 May 2026 with updates
5 May 2026CapitalAllotment of shares (GBP 58.8695) on 25 Mar 2026
15 Apr 2026OfficersTermination of Weng Sie Wong as director on 14 Apr 2026
19 Mar 2026MiscellaneousReplacement filing of SH01 - 05/02/26 Statement of Capital gbp 56.5968
3 Mar 2026MortgageMortgage Create With Deed With Charge Number Charge Creation Date
6 May 2026 Confirmation Statement

Confirmation statement made on 6 May 2026 with updates

5 May 2026 Capital

Allotment of shares (GBP 58.8695) on 25 Mar 2026

15 Apr 2026 Officers

Termination of Weng Sie Wong as director on 14 Apr 2026

19 Mar 2026 Miscellaneous

Replacement filing of SH01 - 05/02/26 Statement of Capital gbp 56.5968

3 Mar 2026 Mortgage

Mortgage Create With Deed With Charge Number Charge Creation Date

Recent Activity

Latest Activity

Confirmation statement made on 6 May 2026 with updates

4 weeks ago on 6 May 2026

Allotment of shares (GBP 58.8695) on 25 Mar 2026

1 months ago on 5 May 2026

Termination of Weng Sie Wong as director on 14 Apr 2026

1 months ago on 15 Apr 2026

Replacement filing of SH01 - 05/02/26 Statement of Capital gbp 56.5968

2 months ago on 19 Mar 2026

Mortgage Create With Deed With Charge Number Charge Creation Date

3 months ago on 3 Mar 2026